secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEXGEL, INC. (NXGL)
CIK:        0001468929
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001493152-26-020657
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NexGel appoints Ian Blackman as CFO; Adam Drapczuk resigns as interim CFO
-------------------------------------------------------------------------

- Ian Blackman appointed CFO effective April 27, 2026; CPA with over 30 years of finance leadership experience.
- Base salary of $250,000; cash bonus tied to EBITDA tiers: 10% at $4M, 30% at $6M, 50% at $8M.
- Received initial option grant for 160,000 shares, 5-year term, vesting over 4 years with acceleration upon change in control.
- Press release links appointment to advancing Celularity acquisition: definitive agreement to license/acquire regenerative biomaterial products from Celularity (NASDAQ: CELU).
- Adam Drapczuk resigned as interim CFO with no disagreement; will continue providing consulting services.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468929/000149315226020657/0001493152-26-020657-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468929/000149315226020657/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-020657

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer